|
SNX22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.159400E-03 |
| Normal-vs-Stage3 |
1.30220279004334E-11 |
| Normal-vs-Stage4 |
1.88060000017032E-07 |
| Stage1-vs-Stage2 |
2.328300E-02 |
| Stage1-vs-Stage3 |
3.931000E-01 |
| Stage1-vs-Stage4 |
8.059000E-01 |
| Stage2-vs-Stage3 |
6.588000E-02 |
| Stage2-vs-Stage4 |
7.496300E-02 |
| Stage3-vs-Stage4 |
7.271200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.029700E-04 |
| Normal-vs-Asian |
1.30050000002324E-06 |
| Caucasian-vs-AfricanAmerican |
1.123640E-01 |
| Caucasian-vs-Asian |
3.677800E-01 |
| AfricanAmerican-vs-Asian |
2.862200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2141181917118E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.371400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
1.67865721323324E-12 |
| Normal-vs-Age(61-80Yrs) |
1.03829999997807E-06 |
| Normal-vs-Age(81-100Yrs) |
1.092000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.512040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.202140E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.504110E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.624800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.701870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.054200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.901570E-01 |
| Classical-VS-Follicular |
3.19780000002101E-06 |
| Classical-VS-Other |
5.584000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.519690E-02 |
| Tall-VS-Other |
8.797600E-01 |
| Tall-VS-Normal |
7.25469999962591E-07 |
| Follicular-VS-Other |
3.206600E-01 |
| Follicular-VS-Normal |
2.603900E-03 |
| Other-VS-Normal |
6.933600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.34779981514544E-10 |
| Normal-vs-N1 |
9.52400380782592E-11 |
| N0-vs-N1 |
6.095600E-03 |
|
|
